DJ bonyf NV: Delay in release of financial statements 2022
bonyf NV
bonyf NV: Delay in release of financial statements 2022
30-Jun-2023 / 14:35 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=----------------------------------------------------------------------------------------------------------------------
PRESS RELEASE
Paris, 30 June 2023
Delay in release of financial statements 2022
Ghent (Belgium), 30 June 2023; bonyf NV (Mnemonic: MLBON), a leading manufacturer of oral and denture care products
announces its delay in the preparation and audit of the financial statements for the 2022 financial year
bonyf NV's, CEO and Founder, Mr Jean-Pierre Bogaert, released today an announcement to the company's shareholders
informing them that there will be a delay in the release of the audited financial statements of the company.
Dear Shareholders,
We regret to inform you that bonyf NV was not yet able to publish its audited financial statements 2022.
We understand the importance of timely and transparent financial reporting, and as such, the audited financial
statements will be available by 16 July 2023. The date of the General Meeting of Shareholders is 31 July 2023 at
10.00am.
We apologize for any inconvenience caused, and appreciate your understanding and support. Should you have any questions
or require further information, please do not hesitate to contact our Investor Relations department on
investor@bonyf.com.
Thank you for your continued trust in bonyf NV.
Yours sincerely,
Jean-Pierre Bogaert
CEO bonyf NV
For more information, please visit www.bonyf.com.
bonyf's strengths
-- Products with patented formulations
-- Produced in Switzerland compliant with stringent international quality regulations
-- Proven clinical efficacy
-- Commercial presence in 37 countries
-- Prospects for solid growth and rapid profitability
-- A fast-growing oral and dental care market
About bonyf
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care
products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to
people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown
dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide.
Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future
development, driven by the fast-growing oral and dental care market.
Learn more at https://bonyf.com
bonyf
Jean-Pierre Bogaert
investor@bonyf.com
=----------------------------------------------------------------------------------------------------------------------
Regulatory filing PDF file
File: Bonyf - PR Delay in release of financial statements 2022 - 300623
=----------------------------------------------------
Language: English
Company: bonyf NV
Doornzelestraat 114 D
9000 Gent
Belgium
Phone: +41 79 412 42 79
E-mail: president@bonyf.com
Internet: www.bonyf.com
ISIN: BE6333353298
Euronext Ticker: MLBON
AMF Category: Inside information / Other releases
EQS News ID: 1670303
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
1670303 30-Jun-2023 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1670303&application_name=news
(END) Dow Jones Newswires
June 30, 2023 08:35 ET (12:35 GMT)
